Skip to content

Clinical trials

Intestinal Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Intestinal Diseases Clear all

260 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20032
20041
20053
20061
20073
20084
200911
20108
201113
20124
201312
201413
201510
201619
201715
201816
201917
202014
202113
202216
202317
202415
202514
202613

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed140
Unknown status45
Recruiting31
Terminated18
Not yet recruiting9
Active, not recruiting6
Enrolling by invitation6
Withdrawn3
Suspended1
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Exact Sciences Corporation6
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)5
Medtronic - MITG5
Menarini Group5
Bausch Health Americas, Inc.4
Pharmbio Korea Co., Ltd.4
Assistance Publique - Hôpitaux de Paris3
Boston Children's Hospital3
Royal Marsden NHS Foundation Trust3
University of British Columbia3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Intestinal Diseases260
Gastrointestinal Diseases88
Digestive System Diseases82
Colonic Diseases55
Intestinal Neoplasms40
Colorectal Neoplasms39
Gastrointestinal Neoplasms38
Rectal Diseases37
Digestive System Neoplasms35
Neoplasms35

Trials

Showing 1 to 25 of 260. Each trial links to its page on Pharma Observatory.

160 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.